Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.130
+0.060 (2.90%)
At close: Aug 26, 2026, 4:00 PM EDT
2.130
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:01 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $371.2 million as of August 26, 2026. Its market cap has increased by 5,797.58% in one year.
Market Cap
371.20M
Enterprise Value
246.02M
1-Year Change
5,797.58%
Ranking
Category
Stock Price
$2.13
ChartMarket Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $371.20M, an increase of 394.48%. That is a compound annual growth rate of 34.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 371.20M | 6.01% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 382.41M |
| Lyell Immunopharma | 379.58M |
| Agenus | 376.37M |
| Zentalis Pharmaceuticals | 367.33M |
| DiaMedica Therapeutics | 363.46M |
| InflaRx | 362.53M |
| Sutro Biopharma | 355.50M |
| Abeona Therapeutics | 355.11M |